INSIGHTS ON DRUG DEVELOPMENT
-
From Nanoformed Powder To 3D Printable Ink
3D printing in pharmaceutics is advancing to offer innovative drug delivery applications. Explore the possibilities of forming stable suspension in printing ink from nanoformed materials.
-
Partnering On An Innovative Hydrogel-Based Treatment For Glioblastoma
Treatments for glioblastoma multiforme (GBM) are in high demand. Learn more about the new possibilities for increased dosing and diffusion capabilities offered by nanoformed APIs.
-
The Future Of Small And Large Molecule Bioanalytics — Today
Learn how innovative, emerging technologies are revolutionizing the field of bioanalytics and drug development.
-
CDMO Outsourcing Trends & Benefits In Biologics Manufacturing
The demand for biologics is projected to rise over the next decade. Explore the benefits of partnering with a CDMO as you aim to bring your drug to market.
-
Leveraging The Bolar Exemption To Accelerate Market Access3/17/2023
Gain insight into the changing comparator sourcing landscape, focusing specifically on the instrumental role the Bolar exemption plays in the shift away from dependence on innovators for clinical supplies.
-
Using Advanced Mass Spectrometry To Analyze APIs And Impurities3/17/2023
Characterizing impurities through advanced analytics, including mass spectrometry, is a critical step in ensuring biotherapeutic product quality. Learn more about the growing role of CDMOs in developing these products.
-
Allogeneic Vs. Autologous Cell Therapy: Deciding On Your Product Strategy3/15/2023
As you develop your future cell therapy drug, consider the risks and benefits of using autologous or allogeneic methods to best suit your development and manufacturing needs.
-
The Future Of Plasmid DNA Upstream Optimization3/15/2023
An optimized upstream manufacturing process is crucial for producing the necessary amount of plasmid DNA required for the growing number of therapeutic and vaccine applications available.
DRUG DEVELOPMENT SOLUTIONS
-
Biopharmaceutical start-ups need to navigate the complex path to commercialization. The combination of an extensive product and services portfolios with expert support and knowledge will allow you to accelerate your drug development.
-
We understand stakeholder needs and match them to the widest array of drug delivery solutions to give your therapy the best potential for success on the path from Phase II through scale-up and commercial supply.
-
Choose the right process development and manufacturing partner to guide your company through the many parameters along the drug development process.
-
Learn how Pyxant Labs and ImaBiotech are helping to advance molecules from discovery through clinical development and NDA approval.
-
Improve productivity and cell growth in fed-batch cultures by supplementing the cell culture medium to boost nutrients depleted during culture. HyClone™ Cell Boost™ 1 Supplement provides nutrients such as amino acids and glucose that are suitable for research and bioprocessing applications.